| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14740338.6.4.385 |
| P8608 | Fatcat ID | release_x7pwmcwyu5gerhmrvy2leqzm6u |
| P698 | PubMed publication ID | 17688382 |
| P2093 | author name string | Udho Thadani | |
| Toni L Ripley | |||
| P2860 | cites work | Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group | Q28144874 |
| Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction | Q28186903 | ||
| Current medical management of chronic stable angina | Q28213164 | ||
| Combination of isosorbide dinitrate and hydralazine in blacks with heart failure | Q28292266 | ||
| A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure | Q28328342 | ||
| Intravenous nitroglycerin in acute myocardial infarction | Q28329474 | ||
| Reversal by phenylephrine of the beneficial effects of intravenous nitroglycerin in patients with acute myocardial infarction | Q28329715 | ||
| Effects of intravenous nitroglycerin on left ventricular function and ST segment changes in acute myocardial infarction | Q28330004 | ||
| Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction | Q28341001 | ||
| Side effects of using nitrates to treat angina | Q33154151 | ||
| Intravenous vasodilator therapy in congestive heart failure | Q33348014 | ||
| The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm | Q34224611 | ||
| ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th | Q34347047 | ||
| Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials | Q34560241 | ||
| Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina | Q34662548 | ||
| Pathophysiology and management of right heart ischemia | Q34843114 | ||
| Sildenafil in patients with cardiovascular disease | Q35580630 | ||
| Cardiovascular effects of tadalafil | Q35580633 | ||
| Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). | Q36194182 | ||
| Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension | Q36357686 | ||
| Role of sublingual nitroglycerin in patients with acute myocardial infarction | Q36819504 | ||
| Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug | Q37359995 | ||
| Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia | Q39559126 | ||
| Intravenous nitroglycerine in refractory unstable angina pectoris | Q39561830 | ||
| Relief of refractory angina with continuous intravenous infusion of nitroglycerin | Q39572405 | ||
| Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris | Q39632715 | ||
| Right ventricular infarction complicating left ventricular infarction secondary to coronary heart disease. Frequency, location, associated findings and significance from analysis of 236 necropsy patients with acute or healed myocardial infarction | Q39870764 | ||
| Intravenous nitroglycerin: clinical pharmacology and therapeutic considerations | Q40212440 | ||
| Nitrate tolerance, oxidative stress, and mitochondrial function: another worrisome chapter on the effects of organic nitrates | Q40483858 | ||
| Short and long-acting oral nitrates for stable angina pectoris | Q40587843 | ||
| Ointments and transdermal nitroglycerin patches for stable angina pectoris | Q40587850 | ||
| Nitrates for unstable angina | Q40602830 | ||
| Nitrate Therapy for Congestive Heart Failure | Q40901896 | ||
| Nitrates in the treatment of congestive heart failure | Q40991764 | ||
| Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate. A double crossover study in a coronary care unit | Q41091454 | ||
| Prevention and reversal of nitrate tolerance in patients with congestive heart failure | Q41385091 | ||
| Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure | Q41436504 | ||
| Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition | Q41666888 | ||
| Hydralazine in the management of left ventricular failure | Q41718218 | ||
| Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris | Q42208753 | ||
| Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy | Q42263271 | ||
| Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. | Q44114713 | ||
| Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial | Q44507080 | ||
| Effects of nitroglycerin on left ventricular cavitary size and cardiac performance determined by ultrasound in man. | Q45191932 | ||
| Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure | Q45201796 | ||
| Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study | Q45337067 | ||
| Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study | Q45337509 | ||
| Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril | Q45997140 | ||
| Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide | Q46486218 | ||
| Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure | Q46969882 | ||
| Dynamic changes in left ventricular outflow tract flow velocities after amyl nitrite inhalation in hypertrophic cardiomyopathy | Q52423079 | ||
| Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure | Q54500018 | ||
| The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. | Q54527980 | ||
| Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema | Q58371256 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| unstable angina | Q2032041 | ||
| acute coronary syndrome | Q266018 | ||
| P304 | page(s) | 385-396 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction | |
| P478 | volume | 6 |
| Q36681410 | An Implanted Closed-loop Chip System for Heart Rate Control: System Design and Effects in Conscious Rats |
| Q36193737 | Caveolin as a potential drug target for cardiovascular protection |
| Q38199072 | Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance |
| Q37449790 | Evaluating symptoms to improve quality of life in patients with chronic stable angina |
| Q33812736 | Headache-type adverse effects of NO donors: vasodilation and beyond |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q34823612 | Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers |
| Q41909315 | The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols. |
| Q37042365 | The prince and the pauper. A tale of anticancer targeted agents |
Search more.